ICP
PFE icon

Interchange Capital Partners’s Pfizer PFE Stock Holding History

Interchange Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.28K Buy
+3,600
New +$95.8K ﹤0.01% 284
2025
Q2 		– Sell
-3,600
Closed -$8.28K – 306
2025
Q1 		$8.28K Buy
+3,600
New +$94.2K ﹤0.01% 274

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Interchange Capital Partners's PFE Position: Q1 2026 in Review

Interchange Capital Partners reduced its Pfizer (PFE) stake by 31% in Q1 2026, selling an estimated $155K and leaving 12,998 shares worth $329K. The position accounts for 0.1% of the portfolio, ranked #189.

Interchange Capital Partners first reported a position in PFE in Q4 2020 and has held it in 19 quarters since. The position peaked at $648K in Q4 2020. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Interchange Capital Partners held 12,998 shares of Pfizer worth $329K as of Q1 2026.
  • Interchange Capital Partners sold 5,825 Pfizer shares in Q1 2026, an estimated $155K.
  • Pfizer made up 0.1% of Interchange Capital Partners's portfolio in Q1 2026, its #189 holding.
  • Interchange Capital Partners first reported a position in Pfizer in Q4 2020 and has held it in 19 quarters since.
  • Interchange Capital Partners's Pfizer position peaked at $648K in Q4 2020.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.